focus -WSS

focus

author：entertainment 2025-10-02 23:30:52 - browse：43

LONDON — AstraZeneca said Friday an experimental drug tamped down the progression of a certain type of breast cancer in a Phase 3 trial, a win for the company after the same drug produced underwhelming results in a lung cancer trial over the summer.

The drug, called datopotamab deruxtecan or Dato-DXd for short, succeeded on one of its primary endpoints of improving progression-free survival compared to chemotherapy in certain breast cancer patients who had previously been treated with other therapies.

AstraZeneca, which is developing Dato-DXd with partner Daiichi Sankyo, said that the data for the other primary endpoint of overall survival were not “mature” as of this interim analysis, but that there was a positive trend. The trial is continuing.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Mystery swirls around US soldier who entered North Korea days ago, officials say

knowledge

explore

WSS

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

How a Boston hospital is priming medical residents to use GPT

The (many) problems with a new study criticizing cancer screening

Stanford president’s abrupt resignation sparks debate

How a Boston hospital is priming medical residents to use GPT

Dementia risk linked to living in disadvantaged areas: Study

entertainment

focus

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Amazon on where the company's health care bets are headed next

Medicare details structure of new drug price negotiation program

Amazon on where the company's health care bets are headed next

Affirmative action in medical school literally saved lives

Illumina names Agilent executive as new CEO

BioMarin wins approval for gene therapy to treat hemophilia A

Extensive review finds private equity owners jack up cost of care

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

In rare move, senator releases unverified FBI source report alleging Biden bribe

focus

Covid hospitalizations on the rise, Humana says

Telehealth startups are trying to fill the menopause care vacuum

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

Listen: Biogen's potential pivot, & Illumina's next chapter

What American doctors can learn from their Israeli counterparts

Delta passengers in Vegas fall sick while waiting on flight in triple

Wikipedia

knowledge

explore

entertainment